bromocriptine has been researched along with naltrexone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Flores, CM; Hornby, PJ; Hulihan-Giblin, BA; Kellar, KJ; Lumpkin, MD | 1 |
| Giraldi, T; Perissin, L; Rapozzi, V; Zorzet, S | 1 |
| Armstrong, WE; Crowley, WR; Grosvenor, CE; Parker, SL; Wang, W | 1 |
| Borm, G; Kremer, JA; Rolland, R; Schellekens, LA; Thomas, CM | 1 |
| Keverne, EB; Remfry, CJ; Rosser, AE | 1 |
| Bapna, JS; Ramaswamy, S; Viswanathan, S | 1 |
| Bapna, JS; Pillai, NP; Ramaswamy, S | 1 |
| Corder, CN; Nieder, GL | 1 |
| Ané, M; Blin, O; Fabre, N; Montastruc, JL; Poulik, J; Rascol, A; Rascol, O; Sabatini, U; Senard, JM | 1 |
| Anton, RF | 1 |
| Falbo, A; Palomba, S; Zullo, F | 1 |
3 review(s) available for bromocriptine and naltrexone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
Topics: Alcoholism; Bromocriptine; Dopamine Agonists; Female; Fluoxetine; Humans; Male; Models, Psychological; Naltrexone; Narcotic Antagonists; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic | 1996 |
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.
Topics: Acetylcysteine; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bromocriptine; Clomiphene; Dexamethasone; Drug Resistance; Female; Fertility Agents, Female; Free Radical Scavengers; Glucocorticoids; Gonadotropin-Releasing Hormone; Gonadotropins; Hormone Antagonists; Humans; Hypoglycemic Agents; Infertility, Female; Laparoscopy; Metformin; Naltrexone; Narcotic Antagonists; Octreotide; Ovary; Ovulation Induction; Polycystic Ovary Syndrome | 2009 |
1 trial(s) available for bromocriptine and naltrexone
| Article | Year |
|---|---|
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Naltrexone; Neurologic Examination; Parkinson Disease | 1994 |
12 other study(ies) available for bromocriptine and naltrexone
| Article | Year |
|---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bromocriptine; Haloperidol; Male; Mecamylamine; Methysergide; Morphine; Naltrexone; Narcotic Antagonists; Neurotransmitter Agents; Nicotine; Nicotinic Antagonists; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Nicotinic; Receptors, Opioid; Receptors, Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1992 |
Metastasis and neuroendocrine system in stressed mice.
Topics: Animals; Bromocriptine; Carcinoma; Female; Guanethidine; Lung Neoplasms; Mice; Mitotane; Naltrexone; Neoplasm Metastasis; Neuroimmunomodulation; Reserpine; Stress, Psychological | 1992 |
Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Antagonists; Electric Stimulation; Female; Lactation; Naltrexone; Oxytocin; Pituitary Gland; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasopressins | 1991 |
Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Lactation; Luteinizing Hormone; Naltrexone; Periodicity; Postpartum Period; Progesterone; Prolactin | 1991 |
Restricted exposure of mice to primer pheromones coincident with prolactin surges blocks pregnancy by changing hypothalamic dopamine release.
Topics: Animals; Bromocriptine; Dihydroxyphenylalanine; Dopamine; Female; Hypothalamus; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Naltrexone; Pheromones; Pregnancy; Pregnancy, Animal; Prolactin; Sex Attractants; Time Factors | 1989 |
Prolactin analgesia: tolerance and cross-tolerance with morphine.
Topics: Analgesics; Animals; Bromocriptine; Drug Tolerance; Male; Mice; Morphine; Naltrexone; Prolactin | 1985 |
Analgesic effect of prolactin: possible mechanism of action.
Topics: Analgesics; Animals; Bromocriptine; Male; Mice; Naltrexone; Pituitary Gland; Prolactin | 1983 |
Effects of opiate antagonists on early pregnancy and pseudopregnancy in mice.
Topics: Animals; Bromocriptine; Female; Mice; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Pseudopregnancy | 1982 |